Fluoroquinolones: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) |
||
| Line 17: | Line 17: | ||
**Tendonitis and tendon rupture<ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref> | **Tendonitis and tendon rupture<ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref> | ||
**Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref> | **Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref> | ||
==List of Fluoroquinolones== | |||
{{#ask:[[Is DrugClass::Fluoroquinolone]] |format=ul }} | |||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Latest revision as of 12:43, 30 August 2025
Indications
- UTI (2nd line)
- Prostatitis
- Chlamydia
- PID
- Traveler's Diarrhea
Adverse Effects
- Common adverse effects
- GI and neuro toxicity
- Rash
- QT prolongation
- Hyper/hypoglycemia
- Hematologic toxicity
- Depression/Suicidality
- Black box warning from US FDA
List of Fluoroquinolones
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||